Delayed Cholecystectomy After ERCP in Geriatric Patients: Balancing Surgical Risk and Recurrence Prevention - A Retrospective Study

老年患者行内镜逆行胰胆管造影术后延迟行胆囊切除术:平衡手术风险与预防复发——一项回顾性研究

阅读:1

Abstract

BACKGROUND: Laparoscopic cholecystectomy (LC) is commonly recommended following endoscopic retrograde cholangiopancreatography (ERCP) to reduce the risk of recurrent biliary events (RBE). However, in geriatric patients, this strategy remains controversial due to increased surgical risk, comorbid conditions, and decreased physiologic reserve. This study aimed to evaluate the outcomes of delayed LC in geriatric patients after ERCP for bile duct stone removal, emphasizing the role of individualized treatment planning. METHODS: We retrospectively reviewed medical records of patients aged ≥75 years who underwent ERCP at Her Royal Highness Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University, from January 2018 to December 2023. Patients were grouped based on whether they underwent delayed LC (>6 weeks post-ERCP). Clinical characteristics, RBE incidence, and mortality were analyzed. Multivariate logistic regression was used to identify predictors of RBE. RESULTS: Of 152 geriatric patients (mean age 82.3 years; 48% male), 53.3% had an ASA score ≥3, and the mean Charlson Comorbidity Index was 4.8. Delayed LC was performed in 34.2% of patients. RBE occurred in 8.6% overall, with a median onset of 390 days. The incidence of RBE was significantly lower in patients who underwent delayed LC compared with those managed without surgery (3.8% vs 11.0%, p = 0.035). RBE-related mortality was 0.7%, and surgery-related mortality was 1.9%. Multivariate analysis identified age ≥82 years as the only independent predictor of RBE (OR 5.7, 95% CI 2.15-25.05, p = 0.014). CONCLUSION: Subsequent LC should be considered in geriatric patients to reduce the risk of RBE after ERCP. However, given the low rates of RBE and mortality observed, a wait-and-see strategy may be a reasonable alternative in selected high-risk patients. Treatment decisions should be individualized, considering each patient's comorbidities, surgical risk, and overall health status.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。